Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash & Equivalents (2022 - 2023)

Historic Cash & Equivalents for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $183.0 million.

  • Therapeutics' Cash & Equivalents rose 22449.86% to $183.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $183.0 million, marking a year-over-year increase of 22449.86%. This contributed to the annual value of $47.7 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Cash & Equivalents of $183.0 million as of Q3 2023, which was up 22449.86% from $128.5 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Cash & Equivalents ranged from a high of $185.1 million in Q1 2022 and a low of $8.0 million during Q1 2023